section name header

Pronunciation

sye-ME-ti-deen audio

Indications

REMS

Unlabeled Use:

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Enters breast milk and cerebrospinal fluid.

Metabolism/Excretion: 30% metabolized by the liver; remainder is eliminated unchanged by the kidneys.

Half-life: 2 hr.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CNS: confusion, dizziness, drowsiness, hallucinations, headache.

CV: ARRHYTHMIAS.

GI: constipation, diarrhea, drug-induced hepatitis, nausea.

GU: sperm count, erectile dysfunction.

Endo: gynecomastia.

Hemat: AGRANULOCYTOSIS, APLASTIC ANEMIA, anemia, neutropenia, thrombocytopenia.

Misc: hypersensitivity reactions.

Interactions

Drug-Drug:

Drug-Natural Products:

Route/Dosage

see Calculator

Renal Impairment

Implementation

US Brand Names

Tagamet, Tagamet HB

Canadian Brand Names

Apo-Cimetidine, Novocimetine, Peptol

Classifications

Therapeutic Classification: antiulcer agents

Pharmacologic Classification: histamine h2 antagonists

Availability

(Generic available)

Time/Action Profile

ROUTEONSETPEAKDURATION
PO30 min45–90 min4–5 hr

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code*